Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Dianthus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Dianthus Therapeutics Inc
Rating: 2.10525
Author: Trendlyne DVM scores

about

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next...

50.56 0.25 (0.50%)

New 52W High in past week

90,900

XNAS Volume

XNAS 28 Jan, 2026 1:01 PM (EST)

Not Eligible

Expensive Valuation

8.0 / 100

Technically Bullish

76.2 / 100

1Yr Price target upside is 29%

11 analysts

Dianthus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next...

New 52W High in past week

SWOT Analysis

Dianthus Therapeutics Inc Live Price Chart